Identifying EDCs “impossible” under new EU guidelines

Proposed guidelines from EU regulators would make it “impossible” to identify a substance as an endocrine disruptor in the near term “even if there is evidence that it causes harm”

Proposed guidelines from EU regulators would make it “impossible” to identify a substance as an endocrine disruptors in the near term “even if there is evidence that it causes harm”, the pressure group Pesticides Action Network (PAN) Europe warned on Friday after the publication of a draft guidance document.

The approach is greatly limited by only focusing on adverse effects due to interactions with oestrogen, androgen, thyroid and steroidogenic (EATS) hormones, the NGO said. “As a result, chemicals will not be assessed for endocrine-related diseases of different modalities such as obesity, diabetes, cognition and behavioural dysfunction,” PAN Europe said.

Please sign in to access this article. To subscribe, view our subscription options, or take out a free trial.

Please enter your details

Forgotten password?

Having trouble signing in?

Contact Customer Support at
subs@endseurope.com
or call 020 8267 8120

Not a subscriber?

Take a free trial now to discover the critical insights and updates our coverage offers subscribers.